Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Praxis Precision Medicines, Inc.

NASDAQ: PRAX · Life Sciences · 3 alerts · CIK 1689548

Share price
$310.27Close, Nov 16
Market cap
$8.67B
Shares outstanding
27.95MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Praxis Precision Medicines, Inc. filings on SEC EDGAR ↗

5:02 PM ET 8-K
Investor Presentation

Praxis Precision Medicines Investor Presentation

Praxis Precision Medicines hosted an Investor Day in New York City to detail its commercial strategy and launch plans for ulixacaltamide in essential tremor and relutrigine in DEEs. The company also provided an expanded pipeline update, including plans to initiate studies for ulixacaltamide in Parkinson’s disease and autism spectrum disorder in 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.